Skip to content Skip to footer

Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications

Langgan

Surat Berita

订阅我们的月讯

Subscribe to our

Newsletter